BR-DHAP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BR-DHAP, covering 2022-06-08 to 2022-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP. [Phase 2, Phase 3]